This inventor holds 5 USPTO granted patents, plus 1 CIPO patent. Top assignee: The Procter Gamble Company. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Thomas Glenn Huggins: Innovator in Microbial Detection
Introduction
Thomas Glenn Huggins is a notable inventor based in Mason, OH (US). He has made significant contributions to the field of microbial detection, holding a total of 5 patents. His work focuses on innovative methods for identifying microbial endotoxins and virulence factors in oral samples.
Latest Patents
Huggins' latest patents include groundbreaking inventions such as the "Detection of microbial endotoxins in oral samples using aptamers." This invention is directed to an aptamer composition that comprises various oligonucleotides, which have a binding affinity for specific bacterial species. Another significant patent is "Detection of oral microbial virulence factors," which outlines methods for detecting and quantifying toxins present in the oral cavity. These methods involve providing a biological sample and utilizing reporter cells to measure the activation of Toll-like receptors.
Career Highlights
Huggins is currently associated with The Procter & Gamble Company, where he applies his expertise in microbial detection. His innovative approaches have the potential to enhance oral health diagnostics and improve patient outcomes.
Collaborations
Throughout his career, Huggins has collaborated with talented individuals such as Sancai Xie and Cheryl Sue Tansky. These collaborations have contributed to the advancement of his research and the development of his patented technologies.
Conclusion
Thomas Glenn Huggins is a distinguished inventor whose work in microbial detection is paving the way for advancements in oral health diagnostics. His contributions are significant and continue to impact the field positively.